APTOSE BIOSCIENCES INC Delisting Actions 8-K Filing 2024 - Delisting Aptose Biosciences received a deficiency letter from Nasdaq stating that their recent issuance of securities violated shareholder approval rules.Get access to all SEC 8-K filings of the APTOSE BIOSCIENCES INC